TBPH 净利润历史(2016–2025)
THERAVANCE BIOPHARMA, INC. (TBPH) 年度净利润历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
$105.9MFY2025 · FY2016 以来:-$190.7M → $105.9M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $105.9M | +287.7% |
| FY2024 | -$56.4M | -2.2% |
| FY2023 | -$55.2M | -106.3% |
| FY2022 | $872.1M | +537.3% |
| FY2021 | -$199.4M | +28.3% |
| FY2020 | -$278.0M | -17.6% |
| FY2019 | -$236.5M | -9.7% |
| FY2018 | -$215.5M | +24.5% |
| FY2017 | -$285.4M | -49.7% |
| FY2016 | -$190.7M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议